Diagnos Inc.
ADK.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -40.68% | -35.90% | -42.66% | -57.62% | -65.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -40.68% | -35.90% | -42.66% | -57.62% | -65.85% |
| Cost of Revenue | 0.41% | 4.24% | 10.60% | 18.81% | 24.27% |
| Gross Profit | -8.74% | -14.80% | -34.74% | -94.93% | -167.70% |
| SG&A Expenses | 56.97% | 24.96% | 13.35% | -2.56% | -10.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.44% | 17.91% | 12.45% | 3.77% | -0.26% |
| Operating Income | -41.47% | -22.02% | -18.71% | -14.44% | -14.03% |
| Income Before Tax | -32.65% | -21.50% | -21.11% | -21.38% | -23.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.65% | -21.50% | -21.11% | -21.38% | -23.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.65% | -21.50% | -21.11% | -21.38% | -23.18% |
| EBIT | -41.47% | -22.02% | -18.71% | -14.44% | -14.03% |
| EBITDA | -43.07% | -22.91% | -18.84% | -14.47% | -14.23% |
| EPS Basic | -8.18% | -4.76% | -11.11% | -14.18% | -17.78% |
| Normalized Basic EPS | -9.09% | -5.61% | -11.73% | -14.37% | -17.16% |
| EPS Diluted | -8.18% | -4.76% | -11.11% | -14.18% | -17.78% |
| Normalized Diluted EPS | -9.09% | -5.61% | -11.73% | -14.37% | -17.16% |
| Average Basic Shares Outstanding | 21.17% | 14.85% | 8.94% | 6.42% | 4.63% |
| Average Diluted Shares Outstanding | 21.17% | 14.85% | 8.94% | 6.42% | 4.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |